OPKO HEALTH INC. - COMMON STOCK
1.2200
25-April-24 15:59:59
15 minutes delayed
Stocks
-0.0100
-0.81%
Today's range
1.1900 - 1.2300
ISIN
N/A
Source
NASDAQ
-
OPKO Health Reports Fourth Quarter 2022 Business Highlights and Financial Results
23 Feb 2023 16:05:01 By Nasdaq GlobeNewswire
-
OPKO Health to Report Fourth Quarter 2022 Financial Results on February 23, 2023
16 Feb 2023 11:41:10 By Nasdaq GlobeNewswire
-
OPKO Health to Present at the 41st Annual J.P. Morgan Healthcare Conference
03 Jan 2023 08:00:01 By Nasdaq GlobeNewswire
-
OPKO Health Reports Third Quarter 2022 Business Highlights and Financial Results
08 Nov 2022 16:05:02 By Nasdaq GlobeNewswire
-
OPKO Health to Report Third Quarter 2022 Financial Results on November 8, 2022
01 Nov 2022 08:00:01 By Nasdaq GlobeNewswire
-
OPKO Health Announces Leadership Changes for BioReference Laboratories
16 Aug 2022 16:29:00 By Nasdaq GlobeNewswire
-
OPKO Health Reports 2022 Second Quarter Business Highlights and Financial Results
04 Aug 2022 16:05:07 By Nasdaq GlobeNewswire
-
OPKO Health to Report Second Quarter 2022 Financial Results on August 4, 2022
25 Jul 2022 16:05:00 By Nasdaq GlobeNewswire
-
OPKO Health to Present at the 2022 Jefferies Healthcare Conference
02 Jun 2022 08:00:02 By Nasdaq GlobeNewswire
-
OPKO Health Reports 2022 First Quarter Business Highlights and Financial Results
09 May 2022 16:05:01 By Nasdaq GlobeNewswire
-
09 May 2022 09:23:34 By Nasdaq GlobeNewswire
-
OPKO Health to Report First Quarter 2022 Financial Results on May 9, 2022
05 May 2022 16:05:02 By Nasdaq GlobeNewswire
-
OPKO Health Reports 2021 Fourth Quarter Business Highlights and Financial Results
24 Feb 2022 16:05:01 By Nasdaq GlobeNewswire
-
OPKO Health to Report Fourth Quarter 2021 Financial Results on February 24, 2022
17 Feb 2022 08:00:01 By Nasdaq GlobeNewswire
-
RAYALDEE® Launched in Germany by OPKO Health’s Licensee, VFMCRP
03 Feb 2022 08:30:00 By Nasdaq GlobeNewswire
-
20 Jan 2022 08:00:02 By Nasdaq GlobeNewswire
-
23 Dec 2021 08:00:00 By Nasdaq GlobeNewswire
-
OPKO Health Receives U.S. FDA Approval for the 4Kscore® Test
08 Dec 2021 08:00:02 By Nasdaq GlobeNewswire
-
OPKO Health Announces the Passing of Director Dr. Richard Lerner
06 Dec 2021 08:00:02 By Nasdaq GlobeNewswire
-
OPKO Health Announces Participation in Piper Sandler 33rd Annual Virtual Healthcare Conference
29 Nov 2021 08:00:01 By Nasdaq GlobeNewswire